Orange Book product · Brand (NDA)
GLUCAGON
GLUCAGON
At a glance
Sep 11, 1998
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 11, 1998
28 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
GLUCAGON
Strength
1MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 020928
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025GVOKE VIALDXBrand (NDA)
NDA 212097 · XERIS
- 2019BAQSIMIBrand (NDA)
NDA 210134 · AMPHASTAR PHARMS INC
- 2025GLUCAGONGeneric (ANDA)
ANDA 218813 · CIPLA
- 2025GLUCAGONGeneric (ANDA)
ANDA 214457 · LUPIN
- 2024GLUCAGONGeneric (ANDA)
ANDA 204468 · MYLAN LABS LTD
- 2020GLUCAGONGeneric (ANDA)
ANDA 208086 · AMPHASTAR PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
